Free Trial

FitLife Brands (FTLF) Competitors

FitLife Brands logo
$15.37 +0.27 (+1.79%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$15.40 +0.03 (+0.20%)
As of 05/1/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FTLF vs. SION, KURA, OPT, PRTA, URGN, STOK, MRVI, VERV, GHRS, and MNMD

Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Sionna Therapeutics (SION), Kura Oncology (KURA), Opthea (OPT), Prothena (PRTA), UroGen Pharma (URGN), Stoke Therapeutics (STOK), Maravai LifeSciences (MRVI), Verve Therapeutics (VERV), GH Research (GHRS), and Mind Medicine (MindMed) (MNMD). These companies are all part of the "pharmaceutical products" industry.

FitLife Brands vs.

Sionna Therapeutics (NASDAQ:SION) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, community ranking and media sentiment.

Sionna Therapeutics and FitLife Brands both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave Sionna Therapeutics an outperform vote while only 60.00% of users gave FitLife Brands an outperform vote.

CompanyUnderperformOutperform
Sionna TherapeuticsOutperform Votes
3
100.00%
Underperform Votes
No Votes
FitLife BrandsOutperform Votes
3
60.00%
Underperform Votes
2
40.00%

Sionna Therapeutics currently has a consensus target price of $38.50, indicating a potential upside of 198.45%. FitLife Brands has a consensus target price of $20.50, indicating a potential upside of 33.38%. Given Sionna Therapeutics' higher probable upside, research analysts clearly believe Sionna Therapeutics is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sionna Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

FitLife Brands has a net margin of 13.38% compared to Sionna Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Sionna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Sionna TherapeuticsN/A N/A N/A
FitLife Brands 13.38%28.03%15.13%

FitLife Brands has higher revenue and earnings than Sionna Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sionna TherapeuticsN/AN/AN/AN/AN/A
FitLife Brands$64.47M2.20$5.30M$0.8418.30

In the previous week, Sionna Therapeutics and Sionna Therapeutics both had 3 articles in the media. Sionna Therapeutics' average media sentiment score of 0.84 beat FitLife Brands' score of 0.29 indicating that Sionna Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sionna Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
FitLife Brands
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

2.3% of FitLife Brands shares are owned by institutional investors. 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

FitLife Brands beats Sionna Therapeutics on 8 of the 12 factors compared between the two stocks.

Get FitLife Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTLF vs. The Competition

MetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$141.70M$1.16B$5.47B$7.92B
Dividend YieldN/AN/A5.11%4.22%
P/E Ratio18.1910.0722.5118.54
Price / Sales2.2010.21397.62103.35
Price / Cash19.0510.4038.1834.62
Price / Book5.061.466.734.25
Net Income$5.30M-$54.34M$3.22B$248.18M
7 Day Performance10.97%3.14%1.58%1.25%
1 Month Performance29.70%25.96%4.05%3.76%
1 Year Performance8.70%-35.54%15.75%5.28%

FitLife Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTLF
FitLife Brands
4.1629 of 5 stars
$15.37
+1.8%
$20.50
+33.4%
+8.7%$141.70M$64.47M18.1920Short Interest ↑
SION
Sionna Therapeutics
N/A$12.04
-0.8%
$38.50
+219.8%
N/A$531.25MN/A0.0035Positive News
Gap Down
KURA
Kura Oncology
4.1317 of 5 stars
$6.51
+1.2%
$25.50
+291.7%
-68.0%$525.87M$53.88M-2.76130Analyst Forecast
News Coverage
OPT
Opthea
0.911 of 5 stars
$3.41
+7.2%
$1.33
-60.9%
+0.9%$524.84M$87,666.000.008News Coverage
Gap Up
PRTA
Prothena
3.4234 of 5 stars
$9.65
-0.5%
$55.00
+469.9%
-59.3%$519.43M$135.16M-4.20130Upcoming Earnings
URGN
UroGen Pharma
4.2958 of 5 stars
$11.26
+14.1%
$32.86
+191.8%
-20.8%$519.02M$90.40M-3.57200Analyst Forecast
Analyst Revision
News Coverage
High Trading Volume
STOK
Stoke Therapeutics
3.5108 of 5 stars
$9.47
-3.0%
$24.67
+160.5%
-14.6%$517.03M$36.56M-4.51100Upcoming Earnings
Positive News
MRVI
Maravai LifeSciences
4.0223 of 5 stars
$2.01
-2.0%
$6.34
+215.6%
-75.9%$511.22M$259.19M-1.23610Upcoming Earnings
Options Volume
VERV
Verve Therapeutics
3.7296 of 5 stars
$5.73
-0.5%
$25.75
+349.4%
-8.3%$508.80M$32.33M-2.33110Positive News
GHRS
GH Research
1.9531 of 5 stars
$9.40
-1.4%
$30.86
+228.3%
-9.9%$489.06MN/A-11.9010News Coverage
Positive News
MNMD
Mind Medicine (MindMed)
2.3047 of 5 stars
$6.36
+2.1%
$25.11
+294.8%
-30.1%$479.34MN/A-2.8140Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:FTLF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners